RAFAEL HOLDINGS, INC. Restricted Cash, Current
RAFAEL HOLDINGS, INC. (RFL) had Restricted Cash, Current of $660.00 thousand as of 2022-10-31, per its 10-Q filed 2022-12-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2022-12-13
- 2022-10-31: Restricted Cash, Current $660.00K.
- 2022-01-31: Restricted Cash, Current $5.00M.
- 2021-10-31: Restricted Cash, Current $5.00M.
- 2021-07-31: Restricted Cash, Current $5.00M.
| Period end | Restricted Cash, Current |
|---|---|
| 2022-10-31 | $660.00K 10-Q · filed 2022-12-13 |
| 2022-01-31 | $5.00M 10-Q · filed 2022-03-17 |
| 2021-10-31 | $5.00M 10-Q/A · filed 2022-02-28 |
| 2021-07-31 | $5.00M 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |